Cassava Sciences | PTIE - Interest Expense On Debt


Cassava Sciences reported $129.73M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
Amgen USD 685M 9M Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Eisai JPY 1.44B 526M Sep/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Geron USD 8.64M 128K Sep/2025
J&J USD 18M 290M Sep/2025
Merck USD 327M 22M Sep/2025
Novartis USD 281M 8M Sep/2025
Pfizer USD 652M 2M Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025